Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 247,400 | 184,800 | 172,700 | 289,600 | 251,100 |
| Marketable Securities | N/A | N/A | N/A | 2,700 | 3,900 |
| Receivables | 1,164,600 | 1,148,500 | 1,124,900 | 1,146,900 | 1,174,300 |
| Inventories | 713,500 | 709,000 | 677,000 | 725,400 | 711,200 |
| Other current assets | 232,100 | 251,800 | 228,800 | 240,100 | 251,000 |
| TOTAL | $2,357,600 | $2,294,100 | $2,203,400 | $2,404,700 | $2,391,500 |
| Non-Current Assets | |||||
| PPE Net | 2,456,700 | 2,478,400 | 2,513,500 | 2,453,600 | 2,455,800 |
| Intangibles | 0 | 0 | 1,904,000 | 0 | 0 |
| Other Non-Current Assets | 2,319,900 | 2,280,100 | 363,900 | 2,264,500 | 2,297,900 |
| TOTAL | $4,776,600 | $4,758,500 | $4,781,400 | $4,718,100 | $4,753,700 |
| Total Assets | $7,134,200 | $7,052,600 | $6,984,800 | $7,122,800 | $7,145,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 353,900 | 352,800 | 325,500 | 358,300 | 351,100 |
| Accounts payable and accrued liabilities | 663,500 | 654,400 | 678,100 | 665,900 | 699,000 |
| TOTAL | $2,167,700 | $2,261,500 | $2,123,500 | $2,155,900 | $2,080,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,283,700 | 2,950,300 | 2,812,000 | 3,083,300 | 2,958,200 |
| Other Non-Current Liabilities | 759,900 | 738,700 | 722,300 | 634,300 | 630,400 |
| TOTAL | $4,493,900 | $4,148,100 | $4,014,900 | $4,158,600 | $3,989,500 |
| Total Liabilities | $6,661,600 | $6,409,600 | $6,138,400 | $6,314,500 | $6,070,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,085,177 | 1,094,247 | 1,097,948 | 1,103,430 | 1,109,977 |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 6,052,500 | 5,734,700 | 5,643,600 | 5,457,300 | 5,261,700 |
| Other shareholders' equity | -2,026,000 | -1,855,400 | -1,836,100 | -1,806,900 | -1,688,100 |
| TOTAL | $472,600 | $643,000 | $846,400 | $808,300 | $1,075,100 |
| Total Liabilities And Equity | $7,134,200 | $7,052,600 | $6,984,800 | $7,122,800 | $7,145,200 |